Fda Approved Drug Library | List of Frontiers open access articles

Original Research

Published on 08 Jan 2021

Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation

in Autoimmune and Autoinflammatory Disorders

Linda Voss
Karina Guttek
Annika Reddig
Annegret Reinhold
Martin Voss
Burkhart Schraven
Dirk Reinhold

Frontiers in Immunology

doi 10.3389/fimmu.2020.616570

5,884 views
9 citations

Original Research

Published on 26 Mar 2024

Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer’s disease seed-dependent formation of tau aggregates

in Alzheimer's Disease and Related Dementias

Ahmed Imtiaz
Shotaro Shimonaka
Mohammad Nasir Uddin
Montasir Elahi
Koichi Ishiguro
Masato Hasegawa
Nobutaka Hattori
Yumiko Motoi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1368291

6,244 views
3 citations

Original Research

Published on 28 Apr 2025

Identification of lurasidone as a potent inhibitor of severe fever with thrombocytopenia syndrome virus by targeting the viral nucleoprotein

in Virology

Ting Cheng
Qingcui Xiao
Jing Cui
Shuangjie Dong
Yuqin Wu
Wenqiang Li
Xinya Yang
Lina Ma
Zhiyong Li
Peng Sun

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1578844

3,320 views
3 citations

Original Research

Published on 15 Nov 2022

Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis

in Cancer Molecular Targets and Therapeutics

Dandan Jiang
Peizhi Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1057455

4,043 views
18 citations

Original Research

Published on 22 Oct 2020

Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations

in Pharmacology of Anti-Cancer Drugs

Marika Colombo
Mirko Marabese
Giulia Vargiu
Massimo Broggini
Elisa Caiola

Frontiers in Oncology

doi 10.3389/fonc.2020.532292

7,130 views
10 citations

Original Research

Published on 03 Jun 2022

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity

in Pharmacology of Infectious Diseases

Si-Yu Yuan
Hai-Bo Yu
Zhen Yang
Yi-Ping Qin
Ji-Hua Ren
Sheng-Tao Cheng
Fang Ren
Betty Yuen Kwan Law
Vincent Kam Wai Wong
Jerome P. L. Ng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.837115

4,678 views
5 citations

Original Research

Published on 02 Dec 2021

Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library

in Virology

Junyuan Cao
Siqi Dong
Yang Liu
Minmin Zhou
Jiao Guo
Xiaoying Jia
Yueli Zhang
Yuxia Hou
Ming Tian
Gengfu Xiao

Frontiers in Microbiology

doi 10.3389/fmicb.2021.793519

4,530 views
8 citations

Original Research

Published on 06 Nov 2018

The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses

in Infectious Agents and Disease

Wei Xu
Shuai Xia
Jing Pu
Qian Wang
Peiyu Li
Lu Lu
Shibo Jiang

Frontiers in Microbiology

doi 10.3389/fmicb.2018.02643

19,100 views
43 citations

Articles

Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation

Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer’s disease seed-dependent formation of tau aggregates

Identification of lurasidone as a potent inhibitor of severe fever with thrombocytopenia syndrome virus by targeting the viral nucleoprotein

Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis

Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity

Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library

The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses